glp-1 mean Frontiers GLP-1 Medications: Everything You Need
Description
J Investig Med
Model is coloured as in Fig
Robbins says
Published online 2025
Given the results from recent studies, the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) recommend that patients with T2D and clinical cardiovascular disease (CVD) with inadequate glucose control despite treatment with metformin should receive an SGLT2 inhibitor or GLP-1 receptor agonist
